新兴生物材料阻断PD-1/PD-L1癌症治疗途径
Yi Zhu1, Jiawei Song1, Yansheng Zhu1
1State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China.
下一代生物材料提供了阻止PD-1/PD-L1通路的新方法,改善了癌症免疫疗法,超出了目前的免疫检查点抑制剂 (ICI),以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 生物材料科学 生物材料科学
背景情况:
- 针对PD-1或PD-L1的常规免疫检查点抑制剂 (ICI) 在许多癌症患者中有效性有限.
- 当前ICI面临的挑战需要新的免疫治疗策略.
研究的目的:
- 审查最近对瘤微环境中的PD-L1表达和功能的见解.
- 总结新兴的基于生物材料的 PD-1/PD-L1 抑制剂的替代品.
- 讨论涉及这些新型药物的组合疗法.
主要方法:
- 对PD-L1调节和功能最近文献的回顾性分析.
- 新兴PD-1/PD-L1通路抑制剂的分类 (,核酸,小分子,天然化合物).
- 综合治疗策略与化疗,放射治疗,光疗和声动疗的综合治疗策略的审查.
主要成果:
- 生物材料可以通过减少PD-L1表达,降解PD-L1或阻断相互作用来抑制PD-1/PD-L1通路.
- 组合疗法显示出增强抗癌免疫反应的前景.
- 新兴的策略为传统单克隆抗体提供了替代品.
结论:
- 基于生物材料的免疫疗法代表了PD-1/PD-L1免疫检查点封锁中的范式转变.
- 这些新的策略对改善癌症治疗和患者的治疗结果具有显著的前景.
- 对生物材料的进一步研究可以指导下一代免疫疗法的发展.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
相关概念视频
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...
Frequency-Domain Interpretation of PD Control
The proportional control gain, combined with the...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Emerging Adulthood
